Lotemax Ophthalmic Ointment
New Eye Test May Help Predict Risk of Glaucoma »
"Jan. 4, 2013 -- A new study from Australia may offer a new way of identifying people at risk of glaucoma years before vision loss happens.
Glaucoma is a leading cause of blindness. But because vision damage often occurs gradually, mos"...
Read the New Eye Test May Help Predict Risk of Glaucoma article »
Lotemax Ophthalmic Ointment
INDICATIONS
LOTEMAX® ointment is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery.
DOSAGE AND ADMINISTRATION
Apply a small amount (approximately ½ inch ribbon) into the conjunctival sac(s) four times daily beginning 24 hours after surgery and continuing throughout the first 2 weeks of the post-operative period.
HOW SUPPLIED
Dosage Forms And Strengths
LOTEMAX is supplied sterile in a 3.5 gram tube filled with loteprednol etabonate ophthalmic ointment, 0.5%.
Storage And Handling
LOTEMAX (loteprednol etabonate ophthalmic ointment), 0.5% is a sterile ointment supplied in a tin tube with a pink polypropylene cap in the following size:
3.5 gram (NDC 24208-443-35)
Do not use if tamper evident skirt is visible on bottom of cap.
Storage
Store between 15°–25°C (59°– 77°F).
Manufactured by: Bausch & Lomb Incorporated Tampa, Florida 33637. Revised: 04/2011
Last reviewed on RxList: 6/10/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Lotemax Ophthalmic Ointment Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Daily
Get breaking medical news.
Updated & New
